Clinical Trial Update: Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and efficacy in idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: Kyntra Bio | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED